Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (450)	12/22/2003 11:52:22 AM
From: Jibacoa	Respond to of 3722

VASC Was up 19.2% at the start of trading today, but it is up only 12.76% at present.<g> The stock opened with a good upgap after it announced on Friday, after the marked closed, that it had received FDA approval for its "Pronto extraction catheter", which is indicated for removal of soft thrombus.(Like those found after recent arterial embolism.) bigcharts.marketwatch.com The stock needs to close above its Nov.25 H of 6.99 before it can test its Sep.22 H at 7.47 bigcharts.marketwatch.com On a close above 7.50 it may get to test the $10 level.<g> bigcharts.marketwatch.com In mid-June VAS received FDA approval for its Vari-Lase procedure for treatment of varicose veins. For the current year,the company is expected to lose around $0.75/share (better than the $0.89 in 2002) and in 2004 the loss is expected to be around $0.30 Insiders hold more than 30% and institutions around 15% There are 12.8M out and the float is around 8.7M Bernard